Chemical Exchange Saturation Transfer for Pancreatic Ductal Adenocarcinoma Evaluation
Lixia Wang,Zhengwei Zhou,Srinivas Gaddam,Nan Wang,Yibin Xie,Zixin Deng,Zhaoyang Fan,Anthony G. Christodoulou,Fei Han,Simon K. Lo,Ashley M. Wachsman,Andrew E. Hendifar,Tao Jiang,Stephen J. Pandol,Debiao Li
DOI: https://doi.org/10.1097/MPA.0000000000002059
2022-01-01
Pancreas
Abstract:Objectives The aims of the study are to evaluate the feasibility of using pH-sensitive magnetic resonance imaging, chemical exchange saturation transfer (CEST) in pancreatic imaging and to differentiate pancreatic ductal adenocarcinoma (PDAC) with the nontumor pancreas (upstream and downstream) and normal control pancreas. Methods Sixteen CEST images with PDAC and 12 CEST images with normal volunteers were acquired and magnetization transfer ratio with asymmetric analysis were measured in areas of PDAC, upstream, downstream, and normal control pancreas. One-way analysis of variance and receiver operating characteristic curve were used to differentiate tumor from nontumor pancreas. Results Areas with PDAC showed higher signal intensity than upstream and downstream on CEST images. The mean (standard deviation) values of magnetization transfer ratio with asymmetric analysis were 0.015 (0.034), -0.044 (0.030), -0.019 (0.027), and -0.037 (0.031), respectively, in PDAC area, upstream, downstream, and nontumor area in patient group and -0.008 (0.024) in normal pancreas. Significant differences were found between PDAC and upstream (P < 0.001), between upstream and normal pancreas (P = 0.04). Area under curve is 0.857 in differentiating PDAC with nontumor pancreas. Conclusions pH-sensitive CEST MRI is feasible in pancreatic imaging and can be used to differentiate PDAC from nontumor pancreas. This provides a novel metabolic imaging method in PDAC.